Cargando…
Clozapine reduces infiltration into the CNS by targeting migration in experimental autoimmune encephalomyelitis
BACKGROUND: Atypical antipsychotic agents, such as clozapine, are used to treat schizophrenia and other psychiatric disorders by a mechanism that is believed to involve modulating the immune system. Multiple sclerosis is an immune-mediated neurological disease, and recently, clozapine was shown to r...
Autores principales: | Robichon, Katharina, Patel, Vimal, Connor, Bronwen, La Flamme, Anne Camille |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014621/ https://www.ncbi.nlm.nih.gov/pubmed/32050980 http://dx.doi.org/10.1186/s12974-020-01733-4 |
Ejemplares similares
-
Localisation of clozapine during experimental autoimmune encephalomyelitis and its impact on dopamine and its receptors
por: Robichon, Katharina, et al.
Publicado: (2021) -
Amelioration of experimental autoimmune encephalomyelitis by clozapine is not associated with defective CD4 T cell responses
por: Zareie, Pirooz, et al.
Publicado: (2017) -
Enhanced disease reduction using clozapine, an atypical antipsychotic agent, and glatiramer acetate combination therapy in experimental autoimmune encephalomyelitis
por: Green, Laura K, et al.
Publicado: (2017) -
Treatment with the Antipsychotic Agent, Risperidone, Reduces Disease Severity in Experimental Autoimmune Encephalomyelitis
por: O'Sullivan, David, et al.
Publicado: (2014) -
Clozapine administration enhanced functional recovery after cuprizone demyelination
por: Templeton, Nikki, et al.
Publicado: (2019)